Association of CA-125 with markers of congestion, and effect of empagliflozin on CA-125 in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)
28 August 2023 (15:30 - 15:40)
Organised by: 
About the speaker
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
5 More presentations in this session
Doctor K. Sopova (Mannheim, DE)
Doctor J. Molvin (Malmoe, SE)
Doctor Y. Watanabe (Tokyo, JP)
Ms L. Anido Varela (Santiago de Compostela, ES)
Access the full session
The Event
ESC Congress 2023
28 August 2023
15:30 CET
You may be interested in
Congress Presentation
25 August 2023
Congress Session
31 August 2024
Congress Presentation
